We use cookies

Essential storage keeps the site working (sign-in, theme, this choice). We'd also like to load Google Analytics to understand, in aggregate, how the site is used — never your genetic data. See our Cookie Policy.

EXT2 Gene and rs1064796192: Understanding Hereditary Conditions

rs1064796192
Health Predisposition
Moderate evidenceGene: EXT2

The EXT2 gene is essential for skeletal development and the synthesis of heparan sulfate. Variants in this gene are primarily associated with hereditary multiple osteochondromas (HMO), a condition characterized by the growth of benign cartilage-capped bone tumors.

What each genotype means

T/TLower attention

Common genetic variant

This genotype represents the common form of the rs1064796192 variant in the EXT2 gene. Current scientific databases, including ClinVar, classify this specific genotype as common and do not associate it with the pathogenic loss-of-function mutations known to cause hereditary multiple osteochondromas. If you have concerns about bone health or family history of skeletal conditions, please consult with a medical professional.

This genotype is widely observed as the common, non-pathogenic form of this variant across global populations.

Understanding the EXT2 Gene

The EXT2 gene, located on chromosome 11, provides instructions for creating the exostosin-2 protein. This protein functions as a glycosyltransferase, an enzyme that works in tandem with the exostosin-1 protein to build long chains of heparan sulfate. Heparan sulfate is a complex sugar molecule found on the surface of cells and within the extracellular matrix, playing a critical role in signaling pathways that regulate cell growth and bone development. When the EXT2 gene is functioning correctly, it acts as a tumor suppressor, ensuring that chondrocytes—the cells responsible for cartilage formation—mature and organize properly during skeletal growth. Disruptions to this process can lead to abnormal bone development, as the signaling crosstalk between cells is impaired.

The Role of Variants in Hereditary Conditions

Genetic variants in EXT2 are most notably associated with hereditary multiple osteochondromas (HMO), formerly known as hereditary multiple exostoses. In this condition, individuals develop multiple benign bone tumors, known as osteochondromas, which typically emerge during childhood and adolescence. These growths often occur near the ends of long bones. While these tumors are generally benign, they can cause physical discomfort, angular deformities of the limbs, and a shortened stature. Research indicates that EXT2 variants act through a loss-of-function mechanism, where the protein is either not produced or is unable to perform its role in heparan sulfate synthesis. While HMO is the most common association, specific, rare variants in EXT2 have also been linked to more complex, severe conditions such as seizures-scoliosis-macrocephaly syndrome, which involves neurological and developmental challenges.

Evidence Strength and Clinical Context

The association between pathogenic variants in EXT2 and hereditary multiple osteochondromas is well-established in clinical genetics. Scientific literature, including data from GeneReviews and OMIM, confirms that EXT2 mutations account for approximately 30% to 35% of all HMO cases. The evidence for these pathogenic variants is considered strong, as they directly disrupt the biological pathways required for normal bone formation. However, it is important to note that not all variants in the EXT2 gene are pathogenic. Many variants identified in genomic studies are benign or of uncertain significance. Clinical diagnosis of HMO is typically based on a combination of physical examination, imaging, and genetic testing. If you have concerns about your genetic profile or family history, it is essential to consult with a medical geneticist or a qualified healthcare provider who can interpret results within the context of your personal health history.

Population Frequency and Interpretation

The EXT2 gene is present in all human populations, and variants within it occur with varying frequencies. While some pathogenic variants are rare and often found within specific families, other common variants exist that do not necessarily cause disease. Genomic databases like gnomAD provide insights into the prevalence of these variants across different ancestral groups. It is crucial to understand that the presence of a variant does not automatically imply a diagnosis. Genetic testing results should always be reviewed by a professional who can distinguish between common, benign genetic diversity and rare, pathogenic mutations. Because the clinical presentation of EXT2-related conditions can vary significantly even among family members with the same variant, genetic information should be used as a tool for clinical guidance rather than a definitive predictor of health outcomes.

How common is this variant?

The EXT2 gene contains many common variants across global populations, though specific pathogenic mutations associated with hereditary multiple osteochondromas are generally rare and often family-specific.

Frequently asked questions

What is hereditary multiple osteochondromas?

Hereditary multiple osteochondromas (HMO) is an inherited disorder characterized by the growth of multiple benign cartilage-capped bone tumors. These tumors typically develop during childhood and can affect bone shape and growth.

Are all EXT2 variants harmful?

No, most variants in the human genome are benign and do not cause disease. Only specific, rare variants that disrupt the function of the exostosin-2 protein are associated with conditions like HMO.

Can I use a home DNA test to diagnose EXT2-related conditions?

Direct-to-consumer genetic tests are not diagnostic tools. If you have a family history of bone disorders or concerns about your health, you should consult a physician or a genetic counselor for clinical-grade testing.

Is there a cure for EXT2-related conditions?

There is currently no cure for the underlying genetic cause of HMO. Management typically focuses on monitoring the growth of osteochondromas and surgical intervention if the tumors cause pain, functional impairment, or other complications.

Sources & further reading

Educational information only, last refreshed 10/15/2026. Not medical advice — these associations describe population statistics, not individual predictions.

Curious what your genotype is for rs1064796192?

Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.

Get my report — $29